Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “PRECISION GENOME ENGINEERING, INC.”

2 pharma patents match "PRECISION GENOME ENGINEERING, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 2 pharmaceutical patents matching "PRECISION GENOME ENGINEERING, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2 results for “PRECISION GENOME ENGINEERING, INC.” · 30,257 patents in full index Clear search

  1. US 10006052

    Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and uses thereof

    PRECISION GENOME ENGINEERING, INC. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  2. US 10000746

    LAGLIDADG homing endonuclease cleaving the T cell receptor alpha gene and uses thereof

    PRECISION GENOME ENGINEERING, INC. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.